← Back to Treatments
🏅 FDA Orphan Designation

Makena

hydroxyprogesterone caproate

Manufacturer: AMAG Pharma USA, Inc.

Indicated for:📚 Pancreatic arteriovenous malformation

Indications & Usage

INDICATIONS AND USAGE Hydroxyprogesterone Caproate Injection, USP is indicated in non-pregnant women: for the treatment of advanced adenocarcinoma of the uterine corpus (Stage III or IV); in the management of amenorrhea (primary and secondary) and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as submucous fibroids or uterine cancer; as a test for endogenous estrogen production and for the production of secretory endometrium and desquamation.

💙 Support Programs

View all →
Makena
AMAG Pharma USA, Inc.
Makena
AMAG Pharma USA, Inc.
Hydroxyprogesterone Caproate
Covis
Copay card ↗Apply ↗

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.